Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
JCO Global Oncology|November 17, 2020
Trends in Melanoma Mortality in Brazil: A Registry-Based StudyGuilherme Nader Marta, Rodrigo Ramella Munhoz, Monica La Porte Teixeira, et al.
BMC Cancer|December 15, 2018
Safety and efficacy of cytotoxic chemotherapy in hepatocellular carcinoma after first-line treatment with sorafenibLeonardo Gomes da Fonseca, Guilherme Nader Marta, Maria Ignez Freitas Melro Braghiroli, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 2023
Progression-free survival assessment by local investigators versus blinded independent central review in randomized clinical trials in metastatic breast cancer: A systematic review and meta-analysisFlavia Jacobs, Chiara Molinelli, Diogo Martins-Branco, et al.
Clinical Breast Cancer|March 21, 2024
The Impact of Initial Tumor Response on Survival Outcomes of Patients With HER2-Positive Advanced Breast Cancer Treated With Docetaxel, Trastuzumab, and Pertuzumab: An Exploratory Analysis of the CLEOPATRA TrialVeronique Debien, Elisa Agostinetto, Marco Bruzzone, et al.
Expert Opinion on Investigational Drugs|March 4, 2022
Progress and pitfalls in the use of immunotherapy for patients with triple negative breast cancerElisa Agostinetto, Agnese Losurdo, Guilherme Nader-Marta, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 27, 2025
PSMA-targeted PET imaging in patients with metastatic triple-negative breast cancer: results of the prospective PRISMA trialMartin Manley, Guilherme Nader-Marta, Ayça Arcay Ozturk, et al.
Clinics (Sao Paulo, Brazil)|August 21, 2014
Treatment priorities in oncology: do we want to live longer or better?Guilherme Nader Marta, Luís G Del Nero, Gustavo Nader Marta, et al.
Critical Reviews in Oncology/Hematology|May 30, 2024
Navigating the complexity of PI3K/AKT pathway in HER-2 negative breast cancer: biomarkers and beyondM Sirico, F Jacobs, C Molinelli, et al.
Clinical Breast Cancer|September 21, 2022
Disease Behavior and Treatment Response of Special Histological Types of Triple-Negative Breast CancerRenata Colombo Bonadio, Fabiano de Almeida Costa, Sofia Vidaurre Mendes, et al.
Journal of Global Oncology|September 11, 2018
Analysis of Efficacy and Toxicity Profile of First-Line Sunitinib or Pazopanib in Metastatic Clear Cell Renal Cell Carcinoma in the Brazilian PopulationPedro Isaacsson Velho, Mirella Nardo, Manoel Carlos Leonardi de Azevedo Souza, et al.
Pageof 4